drugset / Trial / NCT00140205

Pharmacokinetics of Leptin Administration During Fasting

NCT00140205

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study will be to determine the correct dose of leptin, a natural hormone secreted by the fat cells, to give to people when they are fasting and also to determine whether giving leptin to a person when he or she is fasting will reverse the changes in hormone levels that occur with fasting.

Timeline

Start
2001-02
Primary completion
2004-06
Completion
2016-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metreleptin Protein / enzyme biologic 0.01 mg/kg Intravenous
Subject Metreleptin Protein / enzyme biologic 0.1 mg/kg Intravenous
Subject Metreleptin Protein / enzyme biologic 0.3 mg/kg Intravenous

Indications

No indication recorded.